Lixisenatide is a type of injectable drug used to treat type 2 diabetes
CAS | 320367-13-3 |
---|---|
Sequence | H–His–Gly–Glu–Gly–Thr–Phe–Thr–Ser–Asp–Leu–Ser–Lys–Gln–Met–Glu–Glu–Glu–Ala–Val–Arg–Leu–Phe–Ile–Glu–Trp–Leu–Lys–Asn–Gly–Gly–Pro–Ser–Ser–Gly–Ala–Pro–Pro–Ser–Lys–Lys–Lys–Lys–Lys–Lys–Nh2 |
Molecular Formula | C215H347N61O65S |
Molar Mass | 4858.49 |
Purity | ≥98% |
Storage Conditions | 2-8℃ |
Packing Specifications | 100mg、1g、10g、100g or at customers request |
The product is only for research and development and export to legal areas, personal use is prohibited
PS: All adverse consequences are at your own risk